Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J Ford

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|October 18, 2012
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of actionGoldie Y L Lui, Peyman Obeidy, Samuel J Ford, et al.
Cell Reports|December 8, 2016
Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In VivoSorina Radulescu, Matthew J Brookes, Pedro Salgueiro, et al.
Annals of Surgical Oncology|July 9, 2023
Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal SarcomaFabio Tirotta, Michael G Fadel, Marco Baia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2022
Current management of benign retroperitoneal tumorsFabio Tirotta, Andrea Napolitano, Sangkyu Noh, et al.
Annals of Surgery|April 15, 2026
Preoperative Radiotherapy and Postoperative Complications Among Patients with Primary Retroperitoneal Sarcoma: A Post Hoc Analysis of the EORTC-62092 (STRASS) Phase 3 Randomized Clinical TrialFabio Tirotta, Lydia Champezou, Marco Fiore, et al.
Cancer Medicine|March 3, 2025
Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal SarcomaPia van der Laan, Fabio Tirotta, Stijn van der Burg, et al.
Current Oncology Reports|January 17, 2023
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine TumoursTahir Shah, Derek M Manas, Samuel J Ford, et al.
Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.
Annals of Surgical Oncology|February 27, 2025
Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional StudyLeah K Winer, Jordan D Fredette, Jill Hasler, et al.
Annals of Surgical Oncology|March 24, 2025
ASO Visual Abstract: Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans-An International, Multi-Institutional StudyLeah K Winer, Jordan D Fredette, Jill Hasler, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|October 18, 2012
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of actionGoldie Y L Lui, Peyman Obeidy, Samuel J Ford, et al.
Cell Reports|December 8, 2016
Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In VivoSorina Radulescu, Matthew J Brookes, Pedro Salgueiro, et al.
Annals of Surgical Oncology|July 9, 2023
Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal SarcomaFabio Tirotta, Michael G Fadel, Marco Baia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2022
Current management of benign retroperitoneal tumorsFabio Tirotta, Andrea Napolitano, Sangkyu Noh, et al.
Annals of Surgery|April 15, 2026
Preoperative Radiotherapy and Postoperative Complications Among Patients with Primary Retroperitoneal Sarcoma: A Post Hoc Analysis of the EORTC-62092 (STRASS) Phase 3 Randomized Clinical TrialFabio Tirotta, Lydia Champezou, Marco Fiore, et al.
Cancer Medicine|March 3, 2025
Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal SarcomaPia van der Laan, Fabio Tirotta, Stijn van der Burg, et al.
Current Oncology Reports|January 17, 2023
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine TumoursTahir Shah, Derek M Manas, Samuel J Ford, et al.
Annals of Surgical Oncology|May 15, 2025
Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) CollaborationStijn J C van der Burg, Marco Fiore, Piotr Rutkowski, et al.
Annals of Surgical Oncology|February 27, 2025
Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional StudyLeah K Winer, Jordan D Fredette, Jill Hasler, et al.
Annals of Surgical Oncology|March 24, 2025
ASO Visual Abstract: Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans-An International, Multi-Institutional StudyLeah K Winer, Jordan D Fredette, Jill Hasler, et al.
Pageof 6